Human BGN(Biglycan) CLIA Kit

The Human BGN (Biglycan) CLIA Kit is a highly advanced and reliable diagnostic tool designed for the accurate detection and quantification of Biglycan in human serum, plasma, and other biological samples. This kit is based on the Chemiluminescent Immunoassay (CLIA) technology, which offers superior sensitivity, specificity, and precision compared to other conventional immunoassay methods. The kit contains all the necessary reagents and components required for the assay, including pre-coated microplates, detection antibodies, standards, and controls. The assay procedure is simple, fast, and user-friendly, with a total assay time of only 2.5 hours. The kit has a wide dynamic range of detection, with a lower limit of detection of 0.05 ng/mL and an upper limit of 100 ng/mL. The Human BGN (Biglycan) CLIA Kit is an ideal tool for researchers and clinicians involved in the study and diagnosis of various diseases and conditions related to Biglycan, such as osteoarthritis, cardiovascular diseases, and cancer. It is a highly reliable and accurate diagnostic tool that provides consistent and reproducible results, making it an essential tool for any laboratory involved in clinical research and diagnosis.